MedPath

Treatment of Diabetic Peripheral Neuropathy through ayurvedic line of management.

Phase 2
Conditions
Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Registration Number
CTRI/2023/10/058822
Lead Sponsor
Dr H S Harshitha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Subjects of Type 2 Diabetes Mellitus, with peripheral (sensory) neuropathy will be included.

2.Subjects of Diabetic peripheral neuropathy with Diabetic Neuropathy Symptom Score - DNS 1-4 will be included.

3.Subjects with Diabetic peripheral neuropathy between the age group of 30 to 70 years irrespective of gender, religion, occupation, and socio economic status will be included.

4.Both fresh cases and treated cases will be included.

Exclusion Criteria

1.Subjects with other complications of diabetes mellitus like diabetic nephropathy, retinopathy, infectious wounds, gangrene and foot ulcers will be excluded.

2.Subjects with uncontrolled diabetes mellitus i.e. FBS >300mg/dL and PPBS

>350 mg/dL will be excluded.

3.Subjects with HbA1c above 9% will be excluded.

4.Subjects with any other systemic disorders which interfere with the intervention will be excluded.

5.Pregnant and lactating women will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessing relief in the symptoms of Diabetic peripheral neuropathy like burning sensation, pricking, tingling, paresthesia and numbness.Timepoint: at baseline, 11th day (mid assessment) and 31st day (post assessment).
Secondary Outcome Measures
NameTimeMethod
Overall Relief in the symptoms of Diabetic Peripheral Neuropathy & improvement in quality of life.Timepoint: 31st day.
© Copyright 2025. All Rights Reserved by MedPath